“With year-to-date revenue growth of 19%, 16% organic growth, EBIT growth of 18% and a solid operating profit margin of 24% Chr. Hansen continues to deliver a strong performance. Organic growth for the group remained strong in Q3. Driven by the continued move from synthetic to natural colors, the Natural Colors Division once again delivered a strong performance, while organic growth in the Cultures & Enzymes Division was more modest,” says CEO Lars Frederiksen.
“Based on the continued momentum in the Natural Colors Division, we have upgraded our expectations to the organic revenue growth for the full year from 12-14% to 14-15%. As a result of scalability effects in all divisions and a continued efficiency focus, operating profit (EBIT) margin before special items is still expected to be at or above 25%, despite the increased pressure from the changed business mix.”
Revenue in the first nine months of 2010/11 amounted to EUR 474 million, up 19%
Organic revenue growth of 16% for the first nine months of 2010/11
Operating profit (EBIT) before special items up by 18% to EUR 113 million
In Q3 2010/11 revenue increased by 11% corresponding to an organic revenue growth of 12%
Operating profit margin (EBIT) before special items reached 26% in Q3
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. Revenue in FY2009/10 was EUR 576 million. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. There are more than 2,300 dedicated employees in over 30 countries. For further information, please visit www.chr-hansen.com.